These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9052413)

  • 21. Use of monoclonal antibodies to human breast-tumor-associated antigens in fine-needle aspirate cytology.
    Nuti M; Mottolese M; Viora M; Donnorso RP; Schlom J; Natali PG
    Int J Cancer; 1986 Apr; 37(4):493-8. PubMed ID: 3957460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
    Grefte JM; de Wilde PC; Salet-van de Pol MR; Tomassen M; Raaymakers-van Geloof WL; Bulten J
    Acta Cytol; 2008; 52(1):35-44. PubMed ID: 18323273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of a possible new protein marker for differential diagnosis between metastatic carcinoma and mesothelioma cells in serous effusions: preliminary findings.
    Donna A; Betta PG; Marchesini A
    Cancer Detect Prev; 1985; 8(1-2):255-60. PubMed ID: 4064046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of carcinoembryonic antigen as an aid in differential diagnosis of cells in pleural and peritoneal effusions.
    Breborowicz D; Gładysz K; Gryska K
    Patol Pol; 1984; 35(1):37-43. PubMed ID: 6493822
    [No Abstract]   [Full Text] [Related]  

  • 31. Utility of the thromboplastin-plasma cell-block technique for fine-needle aspiration and serous effusions.
    Kulkarni MB; Desai SB; Ajit D; Chinoy RF
    Diagn Cytopathol; 2009 Feb; 37(2):86-90. PubMed ID: 19021217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytodiagnosis and marker determination in pleural effusion].
    Odermatt BF; Pedio G
    Schweiz Med Wochenschr; 1986 Dec; 116(49):1709-16. PubMed ID: 3544207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing.
    Kuenen-Boumeester V; van Loenen P; de Bruijn EM; Henzen-Logmans SC
    Acta Cytol; 1996; 40(3):475-9. PubMed ID: 8669182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic interest of the monoclonal antibody CA1 in malignant pleural effusion.
    Font P; Palacìn A; Font J; Faus R; Molina R; Ballesta AM; Cardesa A; Ingelmo M
    Int J Biol Markers; 1987; 2(3):157-60. PubMed ID: 2453591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer].
    Guzman J; Kraft A; Bross KJ; Würtemberger G; Costabel U
    Pneumologie; 1990 Feb; 44 Suppl 1():601-2. PubMed ID: 2164207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.